Atlas Trials

Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

Clinical trial NCT07746908 · COMPLETED

Trial details

NCT number
NCT07746908
Sponsor
Center for Bioequivalence Studies and Clinical Research
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2025-02-06
Primary completion
2025-07-18
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.